During the past decade, Rush Presbyterian - Saint Luke's Med Ctr conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rush Presbyterian - Saint Luke's Med Ctr" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 54 trials, followed by "Glaxo Wellcome" with 7 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored, "Merck Sharp & Dohme LLC" with 3 trials sponsored and "AIDS Clinical Trials Group" with 3 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rush Presbyterian - Saint Luke's Med Ctr" #1 collaborator was "Bristol-Myers Squibb" with 7 trials as a collaborator, "Glaxo Wellcome" with 5 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials as a collaborator, "Hoffmann-La Roche" with 3 trials as a collaborator and "Abbott" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Rush Presbyterian - Saint Luke's Med Ctr" are "HIV Infections" (92 trials), "Cytomegalovirus Retinitis" (6 trials), "Herpes Simplex" (3 trials), "Mycobacterium Avium-Intracellulare Infection" (3 trials) and "Mycobacterium Avium-intracellulare Infection" (3 trials). Many other conditions were trialed in "Rush Presbyterian - Saint Luke's Med Ctr" in a lesser frequency.

Most popular intervention types in "Rush Presbyterian - Saint Luke's Med Ctr" are "Drug" (75 trials), "Behavioral" (2 trials), "Biological" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (27 trials), "Didanosine" (14 trials), "Stavudine" (13 trials), "Lamivudine" (12 trials) and "Indinavir sulfate" (10 trials). Other intervention names were less common.

The vast majority of trials in "Rush Presbyterian - Saint Luke's Med Ctr" are 90 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Rush Presbyterian - Saint Luke's Med Ctr". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 88 completed trials in Rush Presbyterian - Saint Luke's Med Ctr, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rush Presbyterian - Saint Luke's Med Ctr, 5 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 28 trials that are defined as “Not Applicable".